Literature DB >> 12747923

Blood transfusion in sickle cell disease: a cautionary tale.

Graham Serjeant.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12747923     DOI： 10.1016/S0140-6736(03)13293-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Sickle cell disease: selected aspects of pathophysiology.

Authors:  T Alexy; S Sangkatumvong; P Connes; E Pais; J Tripette; J C Barthelemy; T C Fisher; H J Meiselman; M C Khoo; T D Coates
Journal:  Clin Hemorheol Microcirc       Date:  2010       Impact factor: 2.375

2.  Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches.

Authors:  Julia Zhe Xu; Swee Lay Thein
Journal:  Blood       Date:  2022-05-19       Impact factor: 25.476

3.  Low-shear red blood cell oxygen transport effectiveness is adversely affected by transfusion and further worsened by deoxygenation in sickle cell disease patients on chronic transfusion therapy.

Authors:  Jon Detterich; Tamas Alexy; Miklos Rabai; Rosalinda Wenby; Ani Dongelyan; Thomas Coates; John Wood; Herbert Meiselman
Journal:  Transfusion       Date:  2012-08-06       Impact factor: 3.157

4.  Simple chronic transfusion therapy, a crucial therapeutic option for sickle cell disease, improves but does not normalize blood rheology: What should be our goals for transfusion therapy?

Authors:  Jon A Detterich
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

5.  Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis.

Authors:  Barbara P Yawn; Yunfeng Li; Haijun Tian; Jie Zhang; Steve Arcona; Kristijan H Kahler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-06-27

6.  Time to rethink haemoglobin threshold guidelines in sickle cell disease.

Authors:  Samir K Ballas; Frans A Kuypers; Victor R Gordeuk; Jane S Hankins; Alexis A Thompson; Elliott Vichinsky
Journal:  Br J Haematol       Date:  2021-06-15       Impact factor: 8.615

7.  How I Treat Acute and Persistent Sickle Cell Pain.

Authors:  Samir K Ballas
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-09-01       Impact factor: 2.576
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.